Although neither treatment had effect on the total number of tumor associated macrophages (Figure 4H), X-body treatment shifted the bias of macrophage to a more M1 -like pro-inflammatory phenotype as indicated by the expression of iNOS and CD86 (Figure 4I, J). The gene discussed is NOS2; the disease is neoplasm.